Publications 2025

Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, Beishuizen A, Cepelova M, Ceppi F, Fernandez-Teijeiro A, Fosså A, Georgi TW, Hjalgrim LL, Hraskova A, Leblanc T, Mascarin M, Pears J, Landman-Parker J, Prelog T, Klapper W, Ramsay A, Kluge R, Dieckmann K, Pelz T, Vordermark D et al. (2025)
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial
JAMA Oncol, 11 (3), 258-267
DOI 10.1001/jamaoncol.2024.5636, PubMed 39745682

Flølo TN, Tørris C, Riiser K, Almendingen K, Chew HSJ, Fosså A, Albertini Früh E, Hennessy E, Leung MM, Misvær N, Pavel N, Sundar TKB, Sæterstrand TM, Torbjørnsen A, Løyland B, Holmen H (2025)
Digital health interventions to treat overweight and obesity in children and adolescents: An umbrella review
Obes Rev, e13905 (in press)
DOI 10.1111/obr.13905, PubMed 39972996

Forsgren E, Jørgensen RRK, Bentzen H, Riise J, Haaber J, Pasanen A, Kuitunen H, Wader KF, El-Galaly TC, Hutchings M, Glimelius I, Jerkeman M (2025)
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial
Hemasphere, 9 (3), e70101
DOI 10.1002/hem3.70101, PubMed 40104044